| Lactose (India) Ltd | 142 Cr. | 113 | 247/84.3 | 32.4 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.63 Cr. | 1.90 | 4.33/1.90 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,887 Cr. | 449 | 479/192 | 110 | 22.8 | 0.15 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.8 Cr. | 44.2 | 92.2/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 36.5 Cr. | 24.9 | 29.1/17.0 | 38.0 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 63.0 Cr. | 83.6 | 134/78.9 | 16.6 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 51,047 Cr. | 1,810 | 2,286/1,275 | 38.3 | 314 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 325 Cr. | 14.3 | 22.5/10.8 | 19.8 | 8.21 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 731 Cr. | 1,548 | 1,785/635 | 31.2 | 299 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 106 Cr. | 21.1 | 32.0/15.0 | 28.9 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 813 Cr. | 276 | 449/219 | 7.78 | 123 | 0.90 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | 37.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 11.1 Cr. | 4.47 | 9.28/2.11 | 6.33 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 386 Cr. | 398 | 477/112 | 62.2 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,596 Cr. | 1,058 | 1,584/1,045 | 44.8 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 55.2 Cr. | 0.27 | 1.24/0.26 | 3.63 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 46.1 Cr. | 19.2 | 26.3/6.40 | 47.5 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.91 Cr. | 9.81 | 17.2/9.01 | | 22.6 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 178 Cr. | 498 | 896/443 | 9.62 | 563 | 0.30 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 74.2 Cr. | 74.2 | 76.0/26.1 | 190 | 34.1 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,745 Cr. | 1,411 | 2,452/1,345 | 41.3 | 173 | 0.76 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 18.2 Cr. | 39.8 | 88.7/37.6 | 39.6 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 18.8 Cr. | 7.51 | 7.51/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 17.7 Cr. | 118 | 154/63.0 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 39.6 Cr. | 72.4 | 72.4/9.41 | 440 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 30.2 Cr. | 40.0 | 80.0/0.00 | 42.5 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.03 Cr. | 20.1 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,732 Cr. | 562 | 1,028/492 | 27.6 | 72.4 | 0.21 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 87.5 Cr. | 20.3 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.7 Cr. | 23.1 | 43.7/17.4 | 50.9 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 95,316 Cr. | 2,309 | 3,055/2,115 | 57.2 | 376 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 250 Cr. | 433 | 524/241 | 26.2 | 119 | 1.04 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 42.6 Cr. | 29.6 | 62.6/29.6 | 38.3 | 17.7 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 66,722 Cr. | 1,141 | 1,400/994 | 19.5 | 598 | 0.35 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 116 Cr. | 187 | 303/170 | 169 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 868 Cr. | 86.2 | 123/74.0 | 18.8 | 32.5 | 1.74 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 40.2 Cr. | 30.8 | 50.0/21.0 | | 51.2 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 14,515 Cr. | 1,770 | 1,868/919 | 64.8 | 160 | 0.08 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.30 Cr. | 0.65 | 1.45/0.55 | 107 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 244 Cr. | 31.9 | 68.0/30.0 | 13.0 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 8.71 Cr. | 14.9 | 25.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 130 Cr. | 5.52 | 6.57/2.82 | 302 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 62,578 Cr. | 29,455 | 37,000/25,260 | 41.5 | 1,888 | 1.61 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 7,651 Cr. | 844 | 972/550 | 28.7 | 220 | 0.59 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 281 Cr. | 99.2 | 100/31.3 | 67.6 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,636 Cr. | 1,528 | 1,628/535 | | 104 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 21,995 Cr. | 1,353 | 1,870/1,110 | 401 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 882 Cr. | 254 | 330/154 | 20.5 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 590 Cr. | 442 | 568/270 | 12.6 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,289 Cr. | 470 | 950/455 | 26.3 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,600 Cr. | 1,133 | 1,595/991 | 22.6 | 768 | 0.88 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,20,196 Cr. | 3,553 | 3,790/2,886 | 59.5 | 224 | 0.90 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 1,089 Cr. | 118 | 317/98.0 | | 43.7 | 0.42 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,517 Cr. | 16.1 | 24.0/14.1 | 26.6 | 3.62 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 27,729 Cr. | 724 | 1,360/721 | 78.9 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 4,393 Cr. | 193 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,03,847 Cr. | 1,686 | 1,910/1,547 | 35.0 | 324 | 0.95 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,508 Cr. | 563 | 886/441 | 391 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,661 Cr. | 285 | 319/175 | 37.9 | 75.9 | 0.14 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 334 Cr. | 1,151 | 1,680/956 | 19.4 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 7,197 Cr. | 369 | 502/265 | 56.0 | 121 | 0.14 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,450 Cr. | 216 | 232/111 | 181 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 10,927 Cr. | 4,746 | 6,718/4,146 | 29.6 | 340 | 2.47 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 4,042 Cr. | 2,450 | 2,776/1,772 | 36.3 | 335 | 0.82 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,968 Cr. | 5,996 | 6,739/4,904 | 32.5 | 373 | 2.08 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 166 Cr. | 47.0 | 87.5/42.0 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 23,196 Cr. | 5,068 | 5,993/3,701 | 34.3 | 922 | 0.69 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 122 Cr. | 99.2 | 348/81.0 | 8.62 | 80.4 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,511 Cr. | 410 | 582/281 | | 136 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 4,214 Cr. | 830 | 1,998/604 | 49.4 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 22,518 Cr. | 17,550 | 18,100/10,060 | 171 | 1,188 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 311 Cr. | 14.0 | 44.9/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 14,332 Cr. | 800 | 1,505/660 | 8.44 | 425 | 0.75 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,581 Cr. | 47.1 | 91.7/41.7 | 27.9 | 21.1 | 0.43 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,290 Cr. | 183 | 359/162 | 23.7 | 54.4 | 0.44 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 100 Cr. | 63.2 | 130/62.8 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 337 Cr. | 93.8 | 177/90.2 | 44.9 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 89,996 Cr. | 1,971 | 2,403/1,774 | 20.8 | 430 | 0.61 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,053 Cr. | 526 | 980/499 | 12.2 | 335 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 53,151 Cr. | 984 | 995/474 | 77.8 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 892 Cr. | 859 | 1,235/596 | 20.5 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 148 Cr. | 68.7 | 129/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 764 Cr. | 158 | 322/154 | 21.9 | 107 | 1.90 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 665 Cr. | 380 | 500/265 | 23.7 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 17,878 Cr. | 1,123 | 1,275/802 | 36.0 | 414 | 0.44 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 26,615 Cr. | 1,700 | 1,952/1,303 | 38.8 | 221 | 0.91 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,442 Cr. | 216 | 328/193 | 33.0 | 38.0 | 1.16 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 33,410 Cr. | 1,314 | 1,758/1,168 | 37.4 | 274 | 0.30 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,657 Cr. | 90.6 | 127/57.5 | 25.2 | 57.5 | 0.88 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 740 Cr. | 101 | 124/67.2 | 33.6 | 194 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,406 Cr. | 261 | 355/190 | | 106 | 0.08 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,877 Cr. | 233 | 465/229 | 45.4 | 102 | 0.60 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,359 Cr. | 1,598 | 2,786/1,243 | 36.1 | 369 | 0.44 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,355 Cr. | 334 | 504/285 | 54.9 | 60.0 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,390 Cr. | 552 | 628/412 | 28.1 | 153 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 51,502 Cr. | 1,825 | 2,286/1,275 | 38.6 | 314 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 43,885 Cr. | 2,591 | 3,516/1,921 | 46.1 | 101 | 1.62 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 30,727 Cr. | 1,865 | 2,131/1,200 | 26.6 | 610 | 0.95 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,931 Cr. | 426 | 530/359 | 30.8 | 149 | 1.17 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,904 Cr. | 1,608 | 1,910/1,097 | 56.6 | 210 | 0.45 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,00,596 Cr. | 1,205 | 1,406/1,020 | 17.4 | 432 | 0.66 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,904 Cr. | 249 | 322/177 | 26.1 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,21,525 Cr. | 1,504 | 1,673/1,310 | 22.3 | 408 | 0.87 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,815 Cr. | 1,949 | 2,641/1,551 | 25.2 | 416 | 0.30 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 312 Cr. | 106 | 203/95.6 | 154 | 33.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,353 Cr. | 128 | 191/105 | 12.3 | 99.7 | 0.41 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 64.0 Cr. | 39.4 | 72.0/37.7 | 23.0 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 50,825 Cr. | 380 | 406/291 | 140 | 180 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,686 Cr. | 1,670 | 2,215/1,430 | 37.3 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 130 Cr. | 81.9 | 141/76.3 | 18.2 | 48.6 | 1.46 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 444 Cr. | 188 | 188/67.8 | 44.1 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,697 Cr. | 9,079 | 10,691/6,220 | 107 | 308 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,051 Cr. | 710 | 843/544 | 37.6 | 113 | 0.66 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 172 Cr. | 81.8 | 137/81.0 | 6.52 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 67,845 Cr. | 5,674 | 5,787/4,492 | 29.8 | 1,002 | 0.80 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 18,116 Cr. | 922 | 1,124/725 | 28.6 | 271 | 1.22 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 486 Cr. | 852 | 1,540/763 | 77.3 | 688 | 0.58 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 31,555 Cr. | 2,526 | 3,116/2,022 | 32.4 | 345 | 1.10 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,476 Cr. | 311 | 498/258 | 25.4 | 127 | 1.68 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 4,514 Cr. | 491 | 575/312 | 25.2 | 136 | 0.20 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,630.27 Cr | 1,182.75 | | 56.61 | 197.44 | 0.34% | 16.24% | 14.95% | 6.10 |